The FDA is reporting increasing violations involving data integrity. In response, they have issued a draft guidance document. In March of 2015, the MHRA in the UK released a similar document. In this webinar, you'll learn how to avoid a violation. The discussion will include:

  • What is ‘data integrity’?
  • How can we demonstrate data integrity?
  • Original records vs. true copies
  • Integrity of audit trails
  • Static vs dynamic data
  • Issues with shared logins
  • Electronic data as GxP data
  • Audit trail reviews
  • Recent examples of FDA findings involving data integrity violations
  • Plus, live Q & A session

About the Presenter:

Diane Gleinser

Vice President of Life Science Services and Solutions Diane has more than 29 years of experience in the life science industries. As a member of the senior management team at USDM Life Sciences, Diane leads a highly skilled team of implementation and compliance engineers and was instrumental in establishing USDM's Regulatory Compliance focus.

Want our experts to work on your project?

Take the first step towards creating more value with USDM today.

Connect Now

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.